Esperoct

Showing 1 posts of 1 posts found.

novo_flag

European approval for Novo’s Esperoct in haemophilia A

June 21, 2019
Medical Communications, Sales and Marketing Esperoct, Novo Nordisk, haemophilia, pharma

The European Commission has awarded approval to Novo Nordisk’s extended half-life factor VIII therapy Esperoct (turoctocog alfa pegol, N8-GP) for …

Latest content